Hyperthermia and Chemotherapy: Preclinical Considerations
- 1 January 1980
- book chapter
- Published by Springer Nature
- Vol. 74, 285-292
- https://doi.org/10.1007/978-3-642-81488-4_34
Abstract
Malignant cells appear to be selectively sensitive to thermal injury. The precise mechanism of cell death after thermal exposure has not been established, but the phenomenon has been demonstrated by both in vitro and in vivo techniques. Synergy of hyperthermia and chemotherapy has been demonstrated for several agents, but in vitro results are not uniformly confirmed in vivo. In some agents (methyl-CCNU) no synergy was found in vivo. In others (adriamycin) synergy was only demonstrated at drug doses with intolerable toxicity. Studies of the effects of hyperthermia on drug pharmacokinetics are desirable for future clinical trial design.Keywords
This publication has 7 references indexed in Scilit:
- Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.Proceedings of the National Academy of Sciences, 1975
- Thermal Enhancement of Thio-TEPA Cytotoxicity2JNCI Journal of the National Cancer Institute, 1973
- Variation in Sensitivity to Heat Shock during the Cell-cycle of Chinese Hamster Cellsin VitroInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1971
- The biochemical mechanism of selective heat sensitivity of cancer cells: I. Studies on cellular respirationEuropean Journal of Cancer (1965), 1969
- Selective heat sensitivity of cancer cells. Biochemical and clinical studiesCancer, 1967
- Sur l’Existence des Mesures des CondensateursNagoya Mathematical Journal, 1967
- Selective Heating and Cooling of Tissue in Cancer ChemotherapyAnnals of Surgery, 1962